Your browser doesn't support javascript.
loading
Application of the newly published International System for Reporting Serous Fluid Cytopathology in atypical and suspicious diagnosis: a four-year retrospective analysis.
Shen, Yuan; Gosnell, Joseph M; Nawgiri, Ranjana; Muthukumarana, Vidarshi.
Afiliación
  • Shen Y; Department of Pathology and Laboratory Medicine, MD Anderson Cancer Center, Houston, Texas.
  • Gosnell JM; Department of Pathology and Laboratory Medicine, University of Texas Medical Branch, Galveston, Texas.
  • Nawgiri R; Department of Pathology and Laboratory Medicine, University of Texas Medical Branch, Galveston, Texas.
  • Muthukumarana V; Department of Pathology and Laboratory Medicine, University of Texas Medical Branch, Galveston, Texas. Electronic address: pvmuthuk@utmb.edu.
J Am Soc Cytopathol ; 13(4): 303-308, 2024.
Article en En | MEDLINE | ID: mdl-38637263
ABSTRACT

INTRODUCTION:

Serous fluids offer crucial diagnostic insights, but inconsistent analysis hampers reporting quality, especially in indeterminate (ID) categories like atypia of undetermined significance (AUS) and suspicious for malignancy (SFM). The 2020 International System for reporting Serous Fluid Cytopathology (TIS) aims to standardize communication and reduce reporting disparities. This study evaluates TIS's role in AUS and SFM categories within our institution. MATERIALS AND

METHODS:

A 4-year retrospective search of cytopathology reports from December 2015 to December 2019 for AUS and SFM diagnoses in pleural, ascitic, pericardial fluids, and peritoneal washings was performed and results reclassified using TIS definitions. The risk of malignancy (ROM) was calculated for existing and reclassified diagnoses.

RESULTS:

Over 4 years, we received 2998 serous fluid specimens. AUS constituted 2.3% (70 cases), while SFM constituted 0.5% (16 cases). Excluding repeats, 80 cases were TIS-reviewed. Sixteen cases of ID diagnoses were reclassified. Two cases of AUS were changed to negative for malignancy (NFM) and 12 to SFM. Two SFM cases were upgraded to malignancy. ROM shifted from 63% to 60% for AUS and 100% to 85% for SF (TIS's ROM range AUS 66% ± 10%; SFM 82% ± 4.8%).

CONCLUSIONS:

This institution's ID diagnosis rate is low. AUS ROM is challenging but aligns with TIS, primarily favoring benign. All SFM diagnoses are highly suspicious but quantitatively inadequate for definitive malignancy, explaining the elevated ROM. AUS rate should gauge quality, not serve as a catch-all category. Algorithmic cytology with cell blocks and ancillary studies aids reclassification. TIS is user-friendly and is a consistent methodology for standardized reporting. Further studies are needed to evaluate ROM and define reproducible diagnostic criteria for each category for better system utilization.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Citodiagnóstico Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Soc Cytopathol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Citodiagnóstico Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Soc Cytopathol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos